Breaking News

BioSpectra Launches Contract Manufacturing Services

July 24, 2014

Opens new FDA-registered facility in Bangor, PA

BioSpectra, Inc. has launched contract manufacturing services for pharma and biopharma products from its new FDA-registered facility in Bangor, PA. BioSpectra provides custom cGMP purifications, acidifications, acid/base reactions, custom formulations and particle manipulation, along with documented regulatory support.
“BioSpectra is proud of its customer-focused, custom manufacturing capabilities which provide a unique combination of industry-leading quality – from process chemistry through finished end product,” said Richard Mutchler, president of BioSpectra. “Our clients rest assured knowing they are working with a partner who offers written, declared end-use statements detailing the product is designed, engineered, validated and manufactured solely for the purpose it’s being used. Therefore, we confirm in advance the strict controls with which BioSpectra governs its equipment, processes and products.”

Related Packaging:

Related Contract Manufacturing:

Related Compliance:

blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.